Supply of Integrated 12-Panel Drug Testing Kits with Fentanyl Detection

The contract calls for the manufacture and supply of integrated 12-panel rapid drug testing kits capable of detecting fentanyl, designed specifically for use in parole monitoring programs. These kits must hold FDA 510(k) clearance and comply with CLIA regulations to ensure regulatory validity and clinical reliability in a correctional setting. The technical specifications emphasize integration, speed, and accuracy, with the requirement that all twelve panels, including fentanyl, function reliably in a single test device to support efficient and scalable drug enforcement efforts within the Hawaii Department of Corrections and Rehabilitation. The kits are intended for field deployment where immediate, defensible results are critical to public safety and supervision compliance. The solicitation, posted on May 11, 2026, has a response deadline of June 4, 2026, and is classified as a subcontract under NAICS code 325414, indicating it pertains to the manufacturing of in vitro diagnostic products. The contracting authority is the Hawaii office of the Department of Corrections and Rehabilitation, though no specific office address or point of contact is provided. Performance is expected to support statewide parole operations, and the supplier must demonstrate capability to meet stringent regulatory standards and delivery timelines. The procurement is open to qualified vendors capable of producing scalable, compliant, and reliable testing solutions without specifying set-asides or small business preferences.